Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine

BACKGROUND: Congenital CMV remains an unmet medical need worldwide. Naturally acquired CMV immunity in women prior to pregnancy has been shown effective in reducing maternal-fetal transmission. V160 is engineered as a replication-defective CMV, and its replication in culture is controlled by a synth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Adler, Stuart, Lewis, Nicole, Conlon, Anthony, Christiansen, Mark, Al-Ibrahim, Mohamed S, Rupp, Richard, Fu, Tong Ming, Bautista, Oliver, Tang, Huaping, Culp, Timothy, Das, Rituparna, Beck, Karen, Tamms, Gretchen, Musey, Luwy
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631465/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.718
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados